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ABSTRACT 
Introduction:  Cutaneous tuberculosis (TB) accounts for about 2 - 3% of all cases 
of tuberculosis.  It is as a result of direct infection of the skin or immune 
responses to antigenic components of Mycobacterium tuberculosis, known as 
tuberculids.  In sub-Saharan Africa around 70% of patients with tuberculosis are 
co - infected with the human immunodeficiency virus (HIV).  The prevalence of 
HIV in South Africa is approximately 11.4%.  There are no studies in South Africa 
on the manifestations of cutaneous tuberculosis in the setting of HIV infection.                          
Aims:  The objectives of this study were to determine the clinical and 
histopathological spectrum of cutaneous tuberculosis in the Johannesburg area 
and to assess the correlation of HIV infection and CD4 count, on the clinical and 
pathological presentation.     
Patients and Methods:  This was a prospective, hospital-based study conducted 
over a period of 3 ½ years from Oct 2004 - March 2008.  A total of 74 patients 
diagnosed with cutaneous tuberculosis who were seen during the above 
mentioned period were enrolled for the study.  Patients were enrolled from the 
three academic hospitals, Johannesburg, Chris Hani Baragwanath and Helen 
Joseph.  Inclusion criteria included patients aged 10 years and older diagnosed 
with cutaneous tuberculosis.  Patients from whom consent could not be obtained 
and those with lesions caused by non-tuberculous mycobacteria were excluded 
from the study.      
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 The diagnosis was based on clinical and histopathological features as well as 
supportive diagnostic tests.  Data was captured onto Epi-Info spreadsheet and 
then analyzed using STATA data software.  
Results:  The entire clinical spectrum of lesions of cutaneous TB was seen with 
the exception of the nodular and phlebetic tuberculids.  Erythema induratum, a 
tuberculid was the most common form of cutaneous TB accounting for more than 
a third (36.5%) of all cases.  Scrofuloderma was the most common true infection 
accounting for about 29.7% of all cases.  HIV-TB   co-infection rate was 61.4%.  
The histology ranged from a granulomatous inflammation with absence of bacilli 
to a diffuse inflammation with abundance of bacilli.                  
Conclusions:  Despite the high prevalence of TB and high TB-HIV co-infection 
rate, cutaneous tuberculosis infection is still relatively uncommon.  There is a 
however a relative increase in the frequency of true infections particularly 
scrofuloderma in comparison with the studies done previously here in South 
Africa.  The association between HIV positive status and true infections was 
statistically significant with p = 0.024 and was not found to be statistically 
significant between HIV positive status and tuberculids with p = 0.71. 
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PREFACE 
Cutaneous tuberculosis is an uncommon condition affecting mainly black patients 
in South Africa.1-3  There are two main groups, the tuberculids and true 
infections.  Tuberculids are hypersensitivity reactions due to haematogenous 
spread of antigenic components of M. tuberculosis in persons with a moderate or 
high degree of immunity against M. tuberculosis.  Patients with tuberculids have 
an active focus of tuberculosis infection elsewhere in the body.  True infections 
are due to direct inoculation or haematogenous spread of M. tuberculosis 
resulting in the characteristic skin lesions.  
There are no reports of cutaneous tuberculosis in the setting of HIV infection in 
South Africa.  The largest study on cutaneous tuberculosis in this country was 
done over a period of ten years from 1982 - 1993 at Ga-Rankuwa (now George 
Mukhari) hospital, north west of Pretoria.1  It was a retrospective study in which 
data of 92 patients seen during that period was analyzed.  The concluding 
remark of the author pertaining to HIV/AIDS was that its influence on the 
incidence and clinical pattern of cutaneous tuberculosis remained to be seen. 
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CHAPTER 1 
1.1  Introduction   
1.1.1  Definition 
Tuberculosis of the skin is caused mainly by M. tuberculosis and very rarely by 
M. bovis and bacillus Calmette-Guerin (BCG). It can be due to true or direct 
infection of the skin or hypersensitivity reactions to the antigenic components of 
M. tuberculosis.4,5  
1.1.2  Classification 
There is no single satisfactory classification and Beyt et al. modified classification 
was used for the purposes of this study (table1a).   It takes into account host cell 
mediated immunity and the route of infection.  The initial classification of 
cutaneous tuberculosis was proposed by Eugene Beyt and his colleagues from 
the University of Washington, School of Medicine in 1978.  The authors 
examined the records of 34 patients with cutaneous mycobacteriosis and 
subsequently defined a clinically oriented classification system.6  The shortfall of 
that classification system was that tuberculids were not included (table 1b). The 
classification included inoculation TB, secondary and haematogenous TB 
subtypes only.  Skin lesions of TB can be due to an exogenous source as a 
result of direct inoculation of M. tuberculosis as seen in tuberculous chancre, 
warty TB and lupus vulgaris.  
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Skin TB lesions can be from an endogenous source due to direct spread of 
infection from an underlying lymph node as in scrofuloderma, or auto inoculation 
as seen in TB orificialis.  Haematogenous spread of M. tuberculosis may result in 
miliary TB of the skin, lupus vulgaris and tuberculous abscess (gumma).  There 
are 3 recognised tuberculids namely erythema induratum, papulonecrotic 
tuberculid (PNT) and lichen scrofulosorum.  Nodular tuberculid and 
granulomatous phlebitis have recently been described and are extremely rare.7,8                                
Skin TB lesions e.g disseminated TB, lupus vulgaris and papular tuberculids can  
arise as complications of Bacillus Calmette-Guerin (BCG) vaccination. 
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Table 1a.  Modified Beyt et al. classification 
 
I. Inoculation tuberculosis (exogenous source) Tuberculosis chancre 
Warty tuberculosis 
Lupus vulgaris 
II. Secondary tuberculosis (endogenous source) 
      a.Contiguous spread 
      b. Auto-inoculation 
 
 Scrofuloderma    
Orificial tuberculosis                                                                      
III. Haematogenous tuberculosis Miliary tuberculosis 
Lupus vulgaris (some) 
Tuberculous gumma 
IV. Eruptive tuberculosis (the tuberculids) 
1. Micropapular 
2. Papular 
 
3. Nodular 
 
4. Phlebitic 
 
V. Other                                                            
 
Lichen scrofulosorum 
Papulonecrotic tuberculid 
Erythema induratum of Bazin 
Nodular tuberculid 
Phlebitic tuberculid                                   
BCG - related complications    
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Table 1b. Original Beyt et al. suggested classification in 1978 
 
Proposed classification of cutaneous 
mycobacteriosis 
Terms previously used in the literature 
I. Inoculation cutaneous mycobacteriosis  
   from an exogenous source 
Primary inoculation, tuberculous chancre, 
tuberculosis primary complex 
Tuberculosis verrucosa cutis, verruca necrogenica, 
prosector’s wart, tuberculosis cutis verrucosa. 
II. Cutaneous mycobacteriosis from an    
    endogenous source 
      A. Contiguous spread 
      B. Autoinoculation 
 
 
Scrofuloderma, tuberculosis colliguativa cutis 
Orificial tuberculosis, tuberculosis cutis orificialis, 
tuberculosis ulcerosa cutis et mucosae 
III. Cutaneous mycobacteriosis from    
     haematogenous spread 
 
A. Lupus vulgaris 
B. Acute haematogenous 
dissemination 
 
C. Nodules or abscesses  
 
 
Lupus vulgaris, tuberculosis luposa cutis 
Acute miliary tuberculosis of the skin, tuberculosis 
cutis miliaris disseminata, tuberculosis cutis acuta 
generalisata 
Tuberculous gumma, metastatic tuberculous 
abscess 
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1.1.3  History of Cutaneous Tuberculosis   
The genus mycobacterium contains more than 80 species, most of which are 
harmless environmental saprophytes.  Disease-causing mycobacteria other than 
M. tuberculosis are referred to as non-tuberculous mycobacteria.  The term 
mycobacterium was given in 1896 to a large group of bacteria producing    
mould-like pellicles when grown on liquid media.  They are aerobic, acid-fast, 
non-sporing rods with a waxy coating.  There is evidence that M. tuberculosis 
may have preceded recorded history because the changes of spinal tuberculosis 
have been demonstrated in a skeleton of a Neolithic man in ancient Egypt   
(3400 BC).  
Hippocrates (460 - 575 BC) called tuberculosis, phthisis which meant to dry up. 
The history of cutaneous tuberculosis dates back to the Salerno school of 
medicine in the 10th century.9  It was initially recognised only as lupus vulgaris.  
Lupus is derived from the latin word of wolf.  The term lupus vulgaris was coined 
by Robert Willan, the founder of British Dermatology in 1808.  He gave the name 
to a nodular eruption on the face associated with ulceration.  It was however 
William Fox in 1887 who used the term lupus vulgaris specifically for skin 
tuberculosis. 
Foster described the giant cells and epitheloid cells in lupus lesions in 1855 and 
the term tuberculoid for these histopathological changes was recommended by 
Volkman in 1875.  Scrofuloderma initially called scrofulous gumma was first 
described by ancient French writers and Ernest Bernier wrote extensively on its 
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pathogenesis in 1883.  Prosector’s wart was first described by René Laennec in 
1826.  He described a lesion on his own hand and it turned out to be the first 
published case recognizing the association of cutaneous disease and 
mycobacterial infection.  Tuberculous chancre, or primary inoculation TB, 
previously called verruca necrogenica was described by Samuel Wilks in 1862. 
The concept of tuberculids was first introduced by Jean Darier in 1896.          
Hara et al. described the fourth tuberculid, nodular granulomatous phlebitis in 
1997.  Nodular tuberculid was first described here in South Africa in the year 
2000 by Jordaan et al.  Robert Koch discovered the tubercle bacillus in 1882 and 
Demme in 1883 demonstrated tubercle bacillus in tissue sections for the first 
time.  Tuberculin reaction was discovered by Clemens von Pirquet in 1907 and 
Charles Mantoux devised the intracutaneous test in 1908.  
1.1.4  Epidemiology of Tuberculosis 
A third of the world’s population is infected with M. tuberculosis.10-12 There are 
about nine million new cases of tuberculosis and three million deaths annually.  It 
is estimated that 5 million people are co-infected with human immunodeficiency 
virus (HIV) and TB and that three-quarters of these live in sub-Saharan Africa. 
The main reasons for the global TB burden are poverty, overcrowding, poor case 
management and the impact of HIV pandemic.  The incidence rate of TB in 
South Africa is estimated at 940 /100 000 population, a major increase from       
338/100 000 population in 1998.13  It is way over the world health organization 
(WHO) overall incidence of 200/100 000 and has been declared an epidemic. 
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In 2006, South Africa had nearly 453.929 new cases of tuberculosis and in 80% 
of these patients, the infection was confined to the lungs.  Extrapulmonary TB 
constitute around 10 - 20% of cases of TB and cutaneous TB makes up a small 
proportion of about 2 - 3% of these cases.13 There is paucity of large studies 
which have investigated the incidence of cutaneous TB and its relative frequency 
in patients with organ TB as well as its association with HIV infection. 
1.1.5  Immunology of Tuberculosis 
Following infection only 5 - 10% of individuals develop active disease.  Cell 
mediated immunity with sensitized Th1 lymphocytes plays a critical role in 
controlling the infection.14  The interaction of antigen-presenting cells with     
antigen-specific T and B lymphocytes with subsequent production and release of 
the cytokines, interleukins 2 and 12 (IL2, IL12), interferon gamma (IFN-γ), tumour 
necrosis alpha (TNF-α) is an intricate process with many facets still unaccounted 
for.15 In TB infection, the inflammatory process typically gives rise to a 
characteristic tubercle which consists of a focus of epitheloid cells containing a 
variable number of Langhans giant cells.  
Caseation necrosis is due to the death and degeneration of these epitheloid 
cells.  Immunology of cutaneous tuberculosis is poorly understood.  It is thought 
that the clinical variants of skin TB form an immunological spectrum with lupus 
vulgaris at one pole with good immunity and scrofuloderma at the other pole with 
poor immunity.   Warty tuberculosis shows intermediate changes indicating a 
balanced immune response between Th1 and Th2 cytokines.16 
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1.1.6  HIV-TB Co-infection.  
In South Africa the concurrent HIV-TB infection rate is approximately                 
70 - 80%.12,13 In patients with AIDS, the risk of disseminated TB is high with a 
significant mortality rate. The clinical and radiographic appearance of pulmonary 
TB in these patients may be atypical.  Cavitation and a more typical radiographic 
picture may become apparent as part of immune reconstitution inflammatory 
syndrome (IRIS) which occurs when the patients start taking the highly active 
antiretroviral treatment (HAART).                   
T-cell depletion is thought to be the primary immunopathogenic event 
predisposing HIV positive patients to TB.  The TB granuloma in advanced HIV 
disease is unable to contain the bacillus resulting in disseminated or 
extrapulmonary disease.  Regarding therapy, there has been no controlled trials 
of sufficient power to detect differences in response to anti-TB treatment between 
HIV positive and HIV negative patients.  Studies have suggested that standard 
regimens are as effective in HIV-positive as in HIV-negative patients hence the 
recommendation of a 6 or 9 months regimen for both groups.12 However, higher 
drug reactions resistance due to interruption of therapy and higher re-infection 
rates occur in HIV positive patients.13  
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1.2  Clinical subtypes of cutaneous (skin) TB 
There are two main categories, the true skin TB infections and tuberculids.  
A.  True skin TB infections 
1.2.1  Scrofuloderma  
Scrofuloderma results from contiguous extension of an underlying tuberculous 
focus secondary to local tissue breakdown.  The underlying focus may be a 
tuberculous lymph gland, bone, joint or epididymis.17-19  It occurs most often after 
cervical, submandibular, parotid glands infection and less often with axillary, 
inguinal and bone infection.  The tuberculin test is usually positive.  Skin lesions 
first present as firm subcutaneous nodules or as an asymptomatic induration of 
the skin. 
As it enlarges it softens followed by liquefaction with subsequent perforation. 
Ulcers and sinuses develop and discharge watery, purulent or caseous material. 
Histopathology shows an ulcerated dermal abscess with an ill-defined histiocytic 
component.  The margins of the sinuses contain tuberculoid granulomas and true 
tubercles.  The lesions may contain few or lots of bacilli.   Diagnosis is made by 
skin biopsy, tissue culture, fine needle aspiration and a smear with demonstration 
of acid fast bacilli.  Scrofuloderma may heal spontaneously with typical cord-like 
or criss-crossed scars, but the course is generally protracted. 
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1.2.2  Lupus Vulgaris 
This is a post-primary and chronic progressive form of tuberculosis.  It may 
appear at the site of inoculation from an underlying focus as in scrofuloderma or 
BCG scars and via haematogenous or lymphatic spread.  Skin TB lesions 
resembling those of lupus vulgaris have been reported in patients receiving 
intravesical BCG therapy.20  Lupus vulgaris occurs in patients with moderately 
high immunity to tuberculosis with a positive tuberculin test.  It typically presents 
as a single plaque with almost a gelatinous consistency, composed of grouped      
red-brown papules which on diascopic pressure reveal yellow or apple-jelly 
colour.  The lesions of lupus vulgaris may mimick lichen simplex chronicus.21 
The majority of cases are on the head and neck particularly around the nose. 
The prominent histopathological feature is the formation of typical tubercles with 
scanty central caseation surrounded by epitheloid cells and multinucleate giant 
cells.  Old lesions which consists mainly of epitheloid cells may be impossible to 
distinguish from sarcoidal granulomas.  It is paucibacillary and successful culture 
is difficult, reported to be positive in about 6% of cases.22  Diagnosis can also be 
confirmed using polymerase chain reaction (PCR) test.  Lupus vulgaris is a 
chronic  condition and may lead to considerable impairment of function and 
disfigurement.  The most serious complication of chronic lupus vulgaris is the 
development of squamous cell carcinoma.23  
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1.2.3  Primary Inoculation TB (Tuberculous chancre) 
It results from inoculation of mycobacteria into the skin of a host not previously 
infected with tuberculosis.  Inoculation may be through abrasions or minor injury 
and has been reported following needle stick injury, ear piercing and tattooing.  
Tuberculous chancre and the affected regional lymph node which develop          
3 - 8 weeks after infection constitute the primary complex of the skin equivalent 
to a Ghon focus in the lung.24  It mostly affects children but may occur in 
adolescents and young adults.  Common sites include hands, face and lower 
extremities.   
It presents initially as a small papule, scab or wound which develops into a 
painless granulating ulcer.  The lesions become indurated with thick adherent 
crusts.  It may present on the finger as painless paronychia.  Acute non-specific 
inflammatory reaction may be seen on histology.  Acid fast bacilli may be seen 
using the Ziehl Neelsen stain.  The infiltrate may later become more 
granulomatous with caseation, a phase which coincides with disappearance of 
the bacilli.  PPD may be initially negative and later positive.   Diagnosis is verified 
by mycobacterial culture or PCR.25  
1.2.4  Warty Tuberculosis (Tuberculosis Verrucosa Cutis) 
It is caused by exogenous infection in a previously sensitized person and 
presents as an indolent indurated warty plaque, on areas exposed to trauma and 
to infected sputum.26  Common sites include the hands, knees, ankles and 
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buttocks.  Previously, pathologists were liable to acquire warty TB from patients 
or autopsy material hence the name “prosector’s wart”.  It was reported to be the 
most common form of skin TB in Hong Kong in 1995.27  Histology shows 
pseudoepitheliomatous hyperplasia of the epidermis, hyperkeratosis as well as 
suppurative and granulomatous inflammation in the upper and mid dermis.   Acid 
fast bacilli can occasionally be seen.  The lesions progresses slowly and persist 
for years.  Spontaneous remission may occur and usually results in atrophic 
scars.  
1.2.5  Orificial Tuberculosis (Tuberculosis Periorificialis) 
This rare subtype of skin tuberculosis occurs in patients with pulmonary, 
intestinal or anogenital tuberculosis.  The patients are usually severely ill with 
advanced visceral tuberculosis and impaired cell-mediated immunity.  It is a form 
of autoinoculation tuberculosis with large numbers of mycobacteria shed and 
inoculated into the mucous membranes of orifices.  The lesions occur most 
commonly in the mouth and less often in the perineum.   Small red papules break 
down to form painful ulcers which shows no tendency to spontaneous healing.    
It has been reported in association with Kaposi’s sarcoma in an HIV negative 
patient.28 Histopathological changes are variable and mycobacteria are usually 
present. Diagnosis can be confirmed with culture of M. tuberculosis or PCR.29 
Patients with this condition tend to have an unfavourable prognosis. 
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1.2.6  Disseminated Cutaneous (Miliary) Tuberculosis 
It is an extremely rare skin eruption which occurs in association with fulminating 
miliary tuberculosis and is due to haematogenous dissemination of mycobacteria 
into the skin.  It affects young children and immunosuppressed patients such as 
those with HIV/AIDS. 30-34  Cutaneous miliary tuberculosis in a patient with AIDS 
was first reported by Stack et al. in 1990.34  The lesions are variable and consists 
of erythematous or reddish-brown macules, papules, pustules, vesicles, 
subcutaneous nodules or purpuric vasculitic lesions particularly on the trunk.  
The initial focus of infection may be meningeal or pulmonary.  The tuberculin skin 
test is negative.  Skin biopsies show diffuse suppurative inflammation with 
predominantly polymorphonuclear leukocytes and abundance of acid fast bacilli.  
If the patient develops immunity, lymphocytic cuffing of vessels and tubercles 
may occur.  The prognosis is generally poor. 
 1.2.7  Metastatic Tuberculous Abscess (Tuberculous Gumma) 
Tuberculous gumma is caused by haematogenous spread of mycobacteria from 
a primary focus resulting in a single or multiple ulcers usually on the legs.  
Lesions are seen in children and severely immunosuppressed patients.35  
Lesions may start as subcutaneous nodules and progress to form abscesses, 
and ulcers.36 Tuberculous gumma affects mainly the extremities and less often 
the trunk.  The patient may have progressive organ or miliary TB.37 The 
tuberculin test is usually weakly positive.  Histology shows massive necrosis and 
abscess formation with copious amounts of acid-fast mycobacterial bacilli. 
  
14 
B.  Tuberculids 
Tuberculids are due to haematogenous spread of antigenic components of       
M. tuberculosis in persons with a moderate or high degree of immunity against 
M. tuberculosis.  The diagnosis of tuberculids is based on the morphology of the 
lesions, positive PPD and prompt response to anti-TB therapy. 
1.2.8  Erythema Induratum of Bazin  
It is characterized by recurrent tender subcutaneous nodules and ulcerative 
lesions which are often localized to the posterior part of the lower legs.  Erythema 
induratum and nodular vasculitis are clinically and histologically similar but the 
latter does not usually ulcerate and is not associated with TB.  The main 
differential diagnosis is erythema nodosum which is very rarely associated with 
TB, does not usually ulcerate and shows septal panniculitis on histology.  In 
erythema induratum the tuberculin test is positive and active foci of tuberculosis 
may be identified.  Mycobacterial DNA has been found in the skin specimen 
using PCR in up to 70 % of cases.38,39 The pathogenesis is not clear but venous 
stasis, type III antigen-antibody mediated immune (Arthus) reaction and IFN-γ as 
part of the delayed hypersensitivity reaction may play a role.  Histology shows a 
lobular or septo-lobular granulomatous panniculitis, with or without vasculitis and 
coagulative necrosis.  Acid fast bacilli are not identified and culture for                
M. tuberculosis is negative. 
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1.2.9  Papulonecrotic tuberculid (PNT) 
PNT is characterized by recurrent asymptomatic dusky red and necrotic papules 
affecting mainly the extensor aspects of the extremities.  The lesions are 
symmetrically distributed on the elbows, knees, hands, buttocks and ears.  The 
tuberculin test is positive often with a severe or necrotic reaction.  It affects 
mainly young adults with a female to male ratio of around 3:1.  The lesions 
typically heal with varioliform scarring. 
Development of lupus vulgaris from lesions of PNT has been described in a 
landmark paper from South Africa titled “ From Arthus reaction to lupus 
vulgaris”.40 The histology reveals a typical ovoid or wedge shaped area of 
coagulative dermal necrosis surrounded by a palisaded collection of histiocytes. 
Well formed tubercles are not seen.  Granulomatous and lymphocytic vasculitis 
as well as thrombotic occlusion of vessels may be seen.  Acid fast bacilli are not 
identified in the skin lesions except in the chronic cases that are progressing to 
lupus vulgaris.   M. tuberculosis DNA has been demonstrated in 50 - 70% of 
cases.41 
1.2.10  Lichen Scrofulosorum 
This condition was first described by Hebra in 1868.  It is very rare and typically 
affects mainly children and adolescents.  It tends to occur in association with 
tuberculosis in the lymph nodes and bones. Lichen scrofulosorum has been 
reported in a patient with AIDS.42 The lesions consists of closely grouped small 
follicular or parafollicular papules which are skin coloured or reddish brown and 
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are located mainly on the abdomen, chest, back and proximal limbs.43 The 
tuberculin test is positive.  Histology consists of superficial tuberculoid 
granulomas comprised predominantly of epitheloid cells around hair follicles and 
sweat ducts.   Mycobacteria are not seen in the tissue sections and cannot be 
cultured.  
1.2.11  Nodular granulomatous phlebitis (Phlebitic tuberculid) 
It has recently been described as a fourth type of tuberculid by Hara et al. in 
Japan in 1997.  It is characterized by subcutaneous nodules along the course of 
a leg vein.  A similar case was reported in Pretoria in 2006 by Motswaledi and 
Schulz.44 Histology shows epitheloid granulomas with multinucleated Langhans 
type giant cells observed within the walls of cutaneous veins.  M. tuberculosis 
has been detected using the polymerase chain reaction method. 
1.2.12  Nodular tuberculid 
It was first described in South Africa by Jordaan et al. in 2000. It has been  
proposed by the authors as the fifth type of tuberculid.  Only five cases have so 
far been reported in the literature, the first four cases by Jordaan et al. in the 
original paper and the fifth by Friedman et al. in an HIV positive patient in 2005.45   
The lesions consist of red and bluish nodules without ulceration that occur mostly 
on the lower limbs.  The Mantoux test is strongly positive.  Associated organ TB 
may be present.  Histology shows granulomatous inflammation with or without 
vasculitis as well as necrosis at the junction of the dermis (hypodermis) and 
subcutaneous fat.  
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1.3  Diagnosis and Treatment 
The diagnosis of cutaneous TB is based on clinical and histopathological 
features along with supportive diagnostic tests and response to anti-TB therapy. 
Culture still remains the single most important test for definitive diagnosis but it 
takes up to 6 weeks to obtain results.  
1.3.1  Tuberculin test 
It is designed to detect a cell mediated immune response to M. tuberculosis.  It is 
mediated by sensitized T-lymphocytes following an intradermal injection of 
purified protein derivative (PPD).  The test becomes positive between 2 and 10 
weeks following infection and is usually lifelong.  The Mantoux test is the 
standard and offers the highest degree of consistency.  The test is read at         
48 - 72 hours and the diameter of the area of induration not the area of erythema 
is recorded.  Induration of 15mm is considered positive in immunocompetent 
patients, 5mm in immunosuppressed or HIV positive patients and skin induration 
of 0 - 4 mm is negative. 
Induration of 10mm is suggestive of present or past tuberculous infection in UK 
and USA in patients who never received BCG.  Negative reactions occur in 
anergic patients who are usually ill for example those with severe TB, 
malnutrition, viral infections, sarcoidosis, malignancy or if there is no TB infection.     
BCG immunization leads to a positive tuberculin result in immunized children but 
this reaction does not usually persist beyond 10 years.  
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 The Heaf test is performed with a spring-loaded instrument which causes six tiny 
punctures on the skin.  The reaction is measured in grades from I - IV, with 
grades III - IV suggesting past or present TB infection.  
1.3.2  Polymerase chain reaction (PCR) 
In vivo amplification of specific DNA sequences using the PCR has become a 
valuable tool in the rapid detection of slow growing organisms like                      
M. tuberculosis.  Using this technique mycobacterial DNA has been 
demonstrated in different subtypes of cutaneous tuberculosis.  It can be used in a 
variety of pathological specimens including fresh or snap frozen samples as well 
as formalin-fixed tissue sections.  The generic sensitivity of this test is good with 
a high specificity.  Degradation of DNA in archival material, difficulties in 
extracting mycobacterial DNA from the lipid rich cell wall and diminished 
amplification as a result of formalin fixation may decrease its sensitivity and lead 
to false negative results.46  PCR is also useful in distinguishing multibacillary TB 
from infections with atypical mycobacteria and in situations where cultures are 
not performed.  It has been used successfully to identify M. tuberculosis in most 
subtypes of skin TB including lupus vulgaris, scrofuloderma, orificial TB, 
papulonecrotic tuberculid, erythema induratum and nodular granulomatous 
phlebitis.41,46,47 
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1.3.3  New TB immunological assays 
Targeted tuberculin testing for latent tuberculosis infection is a key component of 
tuberculosis control.  Poor specificity of the tuberculin skin test in populations 
vaccinated with BCG and its low sensitivity in immunosuppressed persons has 
prompted research into new immunological assays.  
 Two blood tests (T-SPOT.TB and QuantiFERON -TB Gold ) which are based on 
detection of interferon gamma (IFN-γ) released by T-cells in response to           
M. tuberculosis have recently been described.48  These tests have operational 
advantages and are both significantly more specific and sensitive than the skin 
test.  The tests are also reported to help reduce the false -positive and          
false-negative results inherent in the skin test.  The major advantage of these 
assays is that they are not affected by the BCG vaccination because they utilise 
two proteins which are encoded by a unique genomic segment which is absent 
from all strains of M. bovis BCG and non-tuberculous mycobacteria.  One of the 
problems with these assays is that they cannot be used to distinguish between 
latent and active TB.  Quantiferon - TB Gold uses whole blood whilst T.SPOT.TB 
utilises peripheral blood mononuclear cells.  The precise role and the use of 
these tests in the diagnosis of cutaneous TB has not been elucidated.  These two 
tests are not available in the government (state) hospitals as yet and were not 
used in any patient in our study. 
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1.3.4  Treatment of Tuberculosis 
Skin TB treatment was previously given five times a week in both intensive and 
continuation phases as in pulmonary tuberculosis (table 2a).49  The National TB 
control programme now recommends seven times weekly regimens.  All patients 
on three times weekly regimens were on clinic DOT (direct observed therapy).  
Recommended dosages:  Rifampicin: 10mg/kg, pyrazinamide 20 - 25mg/kg, 
isoniazid : 5 -10mg/kg and ethambutol 15mg/kg (table 2b). Regimen 1: for new 
smear positive patients, new smear negative patients and extrapulmonary 
tuberculosis.  Treatment is with Rifafour (rifampicin, isoniazid, ethambutol and 
pyrazinamide) and pyridoxine for two months then followed by Rifinah (rifampicin 
and isoniazid) for four months during the continuation phase.  
Regimen 2 (retreatment): for previously treated patients after cure, after 
completion, interruption and failure.  Regimen 3: Is given to children with 
tuberculosis up to the age of 8 years.  This regimen is similar to regimen 1 
without pyrazinamide.  Single drug chemoprophylaxis with isoniazid is now being 
recommended in South Africa.  The emergence of multidrug resistance is 
complicating TB treatment.  Multidrug resistant (MDR) tuberculosis defined as     
in vitro resistance to both isoniazid and rifampicin with or without resistance to 
other-anti-TB drugs.  The problem of MDR has been compounded by the 
emergence of extensively drug resistant (XDR) TB which is defined as MDR-TB 
in association with in vitro resistance to any of the fluoroquinolones plus one or 
more of the injectable second-line anti-TB drugs i.e kanamycin, amikacin or 
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capreomycin.  In the study from Tugela Ferry in Kwa Zulu Natal50 the mortality 
rate in patients with XDR-TB exceeded 90% but was found to be only 35% in the 
study from the United States.51 It has been difficult to accurately determine 
clinical outcomes in patients with XDR-TB in some of the studies in which the 
majority of patients were co-infected with HIV and were immunosuppressed.   
1.4  Non-tuberculous mycobacteria (NTM) 
Non-tuberculous (previously called atypical) mycobacteria were first isolated by 
Pinner in 1935.  These are facultative pathogens and saprophytes and do not 
cause tuberculosis.  They produce pulmonary and extrapulmonary lesions and 
less commonly affect the skin.  Non-tuberculous mycobacteria may be 
pathogenic in the setting of HIV/AIDS.  They exist in soil, water and animals.  
Most human disease is acquired from the environment.  Common examples 
include M. ulcerans, M. kansasii, M. scrofuloceum and M. avium intracellulare.  
PCR identification, culture in a special medium or using mycolic acid high 
perfomanic liquid chromatography (HPLL) are used to confirm the diagnosis.  
Clinically the skin lesions present as erosions, papules, nodules and plaques 
some in a sporotrichoid pattern.52  Histopathology may reveal a mixed 
inflammatory infiltrate, epitheloid cell tubercles with or without acid fast bacilli.  
Treatment include surgical excision where feasible, antibiotics e.g tetracyclines, 
clarithromycin, quinolones, sulfamethoxazole plus trimethoprim as well as the     
anti-TB drugs i.e rifampicin, isoniazid and ethambutol.  
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Table 2 (a):  Anti -TB Treatment  (SA Department of Health 2003) 
 
 
Pretreatment 
body weight 
 
Two months 
initial phase    
(5 x week) 
                       
                 Four months continuation phase 
 
RHZE 
(150,75.400,275) 
 
RH(150,75) 
5 x week 
 
RH(300,150) 
5x week 
 
RH(150,150)  
3 x week 
 
RH(300,150)  
3 x week 
30-37 kg 2 tabs  2 tabs  2 tabs  
38-54 kg 3 tabs 3 tabs  3 tabs  
55-70 kg 4 tabs  2 tabs  3 tabs 
71 kg and 
over 
5 tabs  2 tabs  3 tabs 
 
 
Table 2 b 
                     
                    Recommended dose range in mg/kg 
                                    5 x week                                   3 x week 
Isoniazid ( H)             5 mg/kg                                   10 mg/kg 
Rifampicin (R)          10 mg/kg                                  10 mg/kg 
Pyrazinamide (Z)      25 mg/kg                                  35 mg/kg 
Ethambutol (E)         15 mg/kg                                  30 mg/kg 
Streptomycin             15 mg/kg                                  15 mg/kg       
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CHAPTER 2 
PRESENT STUDY 
2.1  Background 
The estimated incidence of tuberculosis in South Africa is 940/100 000.  
Cutaneous tuberculosis accounts for about 2 - 3% of all cases of tuberculosis.          
In sub-Saharan Africa approximately 70 - 80% of patients with TB are co-infected 
with HIV (human immunodeficiency virus).  South Africa has a population of 
approximately 48 million people comprising mainly of four racial groups: blacks, 
whites, Indians and Coloureds (mixed race).  Blacks are in the majority 
accounting for more than 70% of the population.  Johannesburg is in the Gauteng 
province and has a population of around 7.1 million. 
About 5.7 million people are infected with HIV in South Africa with the prevalence 
estimated at 11.4%.11  Amongst blacks the prevalence of HIV is 13.4%.  The HIV 
prevalence differs between males and females with 9.5% amongst males and 
12.8% amongst females.  Gauteng has the second highest HIV prevalence rate 
of 14.8%.  There are about 1500 new HIV infections in South Africa everyday.  
The recent increase of skin diseases amongst our patients has been ascribed to 
the HIV/AIDS epidemic. 53,54 Skin disease affects more than 90% of patients with 
HIV at some stage during the course of their illness. Patients with typical and 
atypical skin lesions of TB are increasingly being seen in our dermatology clinics.  
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2.2  Aims 
The objectives of this study were to determine the clinical spectrum of cutaneous 
tuberculosis in the Johannesburg area and to assess the correlation of HIV 
infection and CD4 count on the clinical and histopathological presentation.   
2.3  Patients and Methods 
2.3.1  Study Design:  This was a prospective hospital-based clinical and    
immuno-pathological study.  Ethics approval was granted by the Ethics 
committee of the University of the Witwatersrand in October 2004. 
2.3.2:  Patients:  A total of 74 (seventy four) patients diagnosed with cutaneous 
tuberculosis that were seen during the period October 2004 to March 2008 at the 
three academic hospitals Johannesburg, Chris Hani Baragwanath and Helen 
Joseph were enrolled for the study.  Patients were also referred from Sizwe TB 
hospital as well as Charles Hurwitz Santa TB centre which is situated next to the 
Chris Hani Baragwanath hospital.  Consent and assent for minors were obtained 
in all cases.  Patients from whom consent could not be obtained those less than 
10 years of age were excluded from the study.  A questionaire was used to 
record the demographic data as well as history of use of HAART and anti-TB 
therapy.  Patients were provided with information leaflets on skin TB.  
The diagnosis was based on clinical and histopathological findings supported by 
other diagnostic procedures which included tuberculin tests, X-rays, fine needle 
aspirates (FNA), culture of skin tissue and sputum and response to anti-TB 
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treatment.  Patients were initially seen after I month of commencement of therapy 
and then 3 monthly until the completion of treatment.  Thereafter the patients 
were seen at 3 and then 6 months post-treatment to assess response to 
treatment and for any relapse.  
2.3.3:  Multiple skin biopsies were done under local anaesthetic using a punch or 
an incision.  One to two biopy specimens were fixed in 10% buffered formalin, 
processed and paraffin embedded for haematoxylin and eosin as well as       
Ziehl-Neelsen staining. The other biopsy specimens were submitted for culture in 
cases of true cutaneous TB infections only and not for tuberculids.  
The histopathologic features were analyzed and recorded by an independent 
histopathologist in the department of Pathology  and were subsequently reviewed 
in our department with the help of a dermatopathologist.  The histopathologic 
features that were recorded included the presence of granulomatous or           
non-granulomatous infiltrate, acid fast bacilli with Ziehl-Neelsen stain, caseous 
necrosis and the presence or absence of vasculitis.    
Culture specimens were submitted to the TB laboratory in a sterile specimen 
bottle.  In the laboratory the skin specimens were crushed using sterile sand, 
decontaminated and then placed into a mycobacterial growth indicator tube 
(MGIT).  The specimens were thereafter incubated in an MGIT machine for up to 
six weeks (42 days).  Positive fluorescence in the tube was picked up by the 
MGIT machine if there was growth.  Sensitivity tests were subsequently done for 
M. tuberculosis.  
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2.3.4:  Blood tests:  HIV testing was done with the patients consent followed by 
CD4 counts in the HIV positive group.  The patients were stratified into three 
groups: HIV negative patients, HIV positive patients and the third group with an 
unknown HIV status.  The other blood tests that were done included full blood 
count, urea and creatinine and erythrocyte sedimentation rate (ESR). 
2.3.5  Mantoux test:  0.1 ml of 1:10 000 dilution of intradermal injection of purified 
protein derivative was injected 10cm below the antecubital fossa on the volar 
aspect of the left forearm using a 27-gauge insulin syringe.  The reaction was 
read at 72 hours and the diameter of the induration and not the erythema was 
recorded.  A reaction of 15mm or more was considered positive in 
immunocompetent patients and 5mm induration was considered positive in HIV 
positive or immunosuppressed patients. 
2.3.6  X-rays:  All patients had chest x-rays (antero-posterior and lateral) done 
prior to commencement of anti-TB therapy. X-rays were reported by the 
radiologist and reviewed by pulmonologists if necessary.      
2.3.7  FNAC (fine needle aspirate cytology):  FNA was done in 3 patients with 
scrofuloderma in which skin biopsies could not be done immediately.  A sterile 
needle was used to aspirate the lesions and the aspirate was placed on a glass 
slide and stained with Ziehl Neelsen to detect acid fast bacilli.  The aspirate was 
also submitted for TB culture. 
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2.3.8  Polymerase chain reaction (PCR) test was not done routinely in our study 
patients because of cost (± R500-00 per specimen) and the observed poor yield 
from paraffin-embedded tissues that was reported (not published) previously in 
our department. PCR test was done in tissue specimens from 9 patients in which 
culture was negative or was not done.  
2.3.9  Photographs of the skin lesions were taken with the patient’s consent.  The 
distribution and morphology of the skin lesions were recorded.  Anonymity of the  
photographs was guaranteed.  
2.3.10  Notification:  All patients with cutaneous TB were notified with the 
department of health through the Infectious disease TB units in the hospitals and 
were subsequently referred to their nearest TB clinics for further treatment. 
2.3.11  Data collection:  Clinical records were reviewed and the data was 
recorded.  A questionnaire form was used to record demographic data.  Data 
included age, gender, occupation, past and family history of TB and drug history 
of anti-TB therapy and HAART.  Results of PPD, X-rays, sputum for acid fast 
bacilli and culture, tissue histopathology, FNA, PCR, ESR, HIV serology, CD4 
count, full blood count were recorded.  Other relevant supportive investigations 
which were done e.g lumbar punctures, abdominal sonars and X-rays of the 
spine, were also recorded.  These data was recorded on the Epi-info data 
software spread sheet then transferred onto STATA software for statistical 
analysis. 
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2.4 Statistical Analysis 
Descriptive statistics of categorical variables were done using frequency 
distribution tables.  Numerical variables were described using mean and 
standard deviations.  Associations between pairs of categorical variables was 
determined using Pearson’s Chi-Square (where necessary Fisher’s exact test). 
Odds ratios together with 95% confidence intervals, for selected associated 
categorical variables were computed.  The student t-test (one tailed and two 
tailed) was used to test for differences between pairs of a numerical variables 
(such as ages of males vs females).  Statistical significance was ascertained at 
the 5% level, thus a p-value of less than 0.05 was significant. 
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CHAPTER 3 
RESULTS 
3.1  Descriptive  
A total of 74 (seventy four) patients diagnosed with cutaneous tuberculosis were 
enrolled.  The group comprised of 93.2% (n = 69) black patients, 5.4% (n = 4) 
coloured patients and 1.4% (n = 1) white patient.  No Indian patients were seen. 
Their ages ranged from 10 years to 66 years, with a mean age of 32.8            
(SD = 12.1) and median of 36.2 years.  The entire clinical spectrum was seen 
except nodular and phlebitic tuberculids as well as skin lesions related to BCG 
vaccination.  The male to female ratio was 1:3 comprising of 25. 3% (n = 18) 
males and 74.7% (n = 56) females (diagram 1).  Fourty five point nine percent   
(n = 34) of patients had true skin TB infections only, 48.7% (n = 36) with 
tuberculids only and 5.4% (n = 4) had two (overlap) TB skin lesions.  The fourth 
patient with dual (overlap) pathology had two tuberculids and that brought the 
total number of patients with tuberculids only, to 50.0% (n = 37). 
Amongst the 74 patients, a total of 78 TB skin lesions were seen due to the 
overlapping (dual) TB skin lesions in the 4 patients (table 3).  The prevalence of 
HIV amongst the study patients was 61.4%.  A total of 70 (94.6%) of the 74 
patients were tested for HIV.  Sixty one point four percent (n = 43/70) of the 
tested patients were HIV positive, 36.5% (n = 27/70) were HIV negative, 5.4%       
(n = 4/74) had an unknown HIV status. (table 4-6).  Sixty seven point six percent 
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(67.6%) of patients with true infections (n = 23/ 34) were HIV positive compared 
to 45.9% with tuberculids (n = 17/37).  This translated to true infections 
accounting for 53.5% (n = 23/43) and tuberculids 39.53% (n = 17/43) of all HIV 
positive patients respectively (table 4,5).  Patients with overlapping or dual TB 
skin lesions were all HIV positive (table 6). The mean CD4 count of all HIV 
positive patients (n = 43) with skin TB was 168.61 (SD = 114.1) cells/µl.  A total 
of 39.2% (n = 29) patients had associated pulmonary tuberculosis.  In this group 
of patients with pulmonary tuberculosis, 58.6% (n = 17) had true cutaneous TB 
infections, 34.5% (n = 10) had tuberculids and 6.8% (n = 2) had overlap TB skin 
lesions. 
A total of 22 patients (29.7% of all cases) were diagnosed with scrofuloderma.   
It was the second most common subtype of skin tuberculosis and the most 
common true cutaneous TB infection accounting for 29.7% (n = 22) of all cases.  
The male to female ratio 1: 2 comprising of 7 males and 15 females with a mean 
age of 29.1 (SD = 11.9) years.  Nineteen patients were black and 3 were 
coloured. Seventy seven point three percent (77.3%, n = 17) patients were HIV 
positive, 18.2% (n = 4) HIV negative and 1 had an unknown HIV status.  The 
seventeen HIV positive patients comprised of 15 patients with scrofuloderma only 
and 2 with dual (overlap) skin lesions.  Their CD4 counts ranged from 38 to 270 
cells/µl with a mean of 145.8 (SD = 74.3) cells/ µl.  A total of 12 patients (70.6%) 
had CD4 count of less than 200 cells/µl and 5 patients (29.4%) had CD4 counts 
of more than 200 cells/µl.  The common sites involved were the cervical (fig 1) 
and submandibular regions. Other sites included the groin, sternum and axilla. 
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Pulmonary tuberculosis was present in 41.0% (n = 9/22) of patients.        
Nineteen patients had skin biopsies done and in 3 patients the diagnosis was 
made using fine needle aspiration cytology (FNAC).  A granulomatous histology 
with multinucleated giant cells was found in 73.7% (n = 14/19) of the biopsy 
specimens.  Non-granulomatous histology was seen in 21.1% (n = 4) cases.  
Acid fast bacilli were seen in 31.8% (n = 7) of the 22 specimens and                  
M. tuberculosis was cultured in 45.5% (n = 10) of the total specimens.  Seven of 
the 10 patients with positive tissue cultures for M. tuberculosis were HIV positive.  
A total of 6 patients had lupus vulgaris.  5 patients had lupus vulgaris only and 
the sixth had lupus vulgaris and PNT.  Their ages ranged from 10 years to 66 
years with a mean age was 29.1 (SD = 20.2) years.  Two patients were HIV 
positive with CD4 counts of 95 and 301cells/µl respectively with a mean of 198 
cell/µl.  PPD was positive in all 6 cases.  Pulmonary tuberculosis was present in 
33.3% (n = 2) of patients.  Skin lesions consisted mainly of nodules (fig 2) and 
plaques involving the face in 5 patients and the leg in 1 patient.  A tuberculoid 
histology with epitheloid cells, histiocytes and Langhans giant cells with variable 
caseation necrosis was seen.  The histology was less granulomatous in the two 
HIV positive patients.  Acid fast bacilli were demonstrated in the skin biopsy of an 
HIV patient with lupus vulgaris and PNT.  One patient had TB spine and systemic 
lupus erythematosus.  Culture for M. tuberculosis was positive in 2 patients, one 
HIV positive patient with acid fast bacilli on histology and an HIV negative patient 
with no acid fast bacilli seen on skin biopsy specimen. 
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Four cases of miliary tuberculosis were seen and accounted for 5.4% of all 
cases.  Their ages ranged from 22 to 60 yrs, with a mean of 44.5 years            
(SD = 10.3).  All patients were terminally ill, HIV positive with CD4 counts ranging 
from 2 to 25 cells/µl and a mean of 9.5 (SD = 10.7) cells/µl.  These patients had 
pulmonary and fulminant disseminated tuberculosis.  Two patients had confirmed 
bone marrow involvement.  Skin lesions consisted of crusted erythematous 
follicular papules, purpuric macules and targetoid lesions (fig 3).  There was 
negative reaction to PPD in all 4 cases.  The histology of the skin biopsies 
showed non-specific inflammation with abundance of acid fast bacilli.                
M. tuberculosis was confirmed on culture (both on sputum and skin tissue). 
Two cases of tuberculous ulcers were seen in patients aged 26 and 28 years. 
Lesions were both on the lower legs.  Both patients were HIV positive with CD4 
counts of 24 and 272 cells/µl and a mean of 148.5 cells/µl (SD = 188.8).  PPD 
was reactive and pulmonary TB was present in one patient.  Histology was     
non-specific, acid fast bacilli were positive in both cases and culture confirmed         
M. tuberculosis in one patient.  
Orificial tuberculosis was seen in an HIV negative 30 year old female.  The 
lesions were in the perianal region and consisted of shallow ulcers with a necrotic 
base (fig 4).  Patient had sputum smear positive pulmonary and hepatic TB with 
a positive culture for M.tuberculosis. PPD was weakly positive and histology 
showed ill-defined granulomas and scanty acid fast bacilli. 
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One case of warty tuberculosis was seen in an HIV positive patient with 
pulmonary tuberculosis.  Her CD4 count was 280.0 cells/µl.  The patient 
presented with a hyperkeratotic plaque on the right hand.  Histology showed              
pseudo-epitheliomatous hyperplasia with a granulomatous infiltrate.  Acid fast 
bacilli were seen on histology and M. tuberculosis was grown on culture. 
A case of primary inoculation tuberculosis was seen on the forefinger of a 
laboratory health worker three weeks after needle stick injury whilst aspirating a 
tuberculous lymph node from a patient.  The patient was initially treated with 
antibiotics.  M. tuberculosis was subsequently cultured from the FNA aspirate 
from that lymph node.  PPD reaction on the laboratory worker was positive. 
Histology showed a granulomatous infiltrate with central caseation necrosis and 
Langhans type giant cells.  A solitary acid fast bacillus was seen on the skin 
biopsy specimen and the response to anti TB therapy was remarkable. 
Erythema induratum was the most common presentation of skin TB and 
accounted for 36.5% (n = 27) of all cases.  Twenty five patients presented with 
erythema induratum only and 2 with dual skin lesions of erythema induratum with 
PNT and erythema induratum with scrofuloderma.  Ninety six point three percent 
(96.3%, n = 26) were females and 3.7% (n = 1) male.  Pulmonary tuberculosis 
was present in 25.9% (n = 7) of the patients with erythema induratum.  Their 
ages ranged from 24 years to 60 years with a mean age 37. 5 (SD =10.1) years. 
Of the total of 25 patients with erythema induratum only, 44.0% (n =11) of 
patients were HIV positive, 48.0% (n = 12) were HIV negative, and 8.0% (n = 2) 
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of patients had an unknown HIV status.  The CD4 counts of these 11 HIV 
positive patients ranged from 150 to 450 cells/µl with a mean of 234.5             
(SD = 116.6) cells/µl.  Fourty five percent (n = 5) of patients had CD4 counts of 
less than 200 cells/µl and 55% (n=6) had CD4 counts of more than 200 cells/µl. 
The lesions were predominantly on the calves and shins (fig 5). Ulceration of the 
skin lesions was present in 44.4% (n = 12) of patients.  Histopathology showed 
predominantly septo-lobular granulomatous panniculitis in 66.7% (n = 18) and 
lobular panniculitis in 33.3% (n = 9) of patients (fig 5).  
The infiltrate associated with focal necrosis and vasculitis was confined mainly to 
the subcutis.  In the HIV positive patients with low CD4 counts of less than100 
cells/µl, the granulomas were poorly formed.  Acid-fast bacilli were not seen in 
any of the skin biopsy specimens.  Tissue specimens were not submitted for 
PCR and culture of M. tuberculosis.  
Thirteen patients were diagnosed with papulonecrotic tuberculid (PNT).  It was 
the third commonest subtype of skin TB accounting for 17.6% (n = 13) of all 
cases.  There were 8 females and 5 males ranging in age from 10 to 38 years 
with a mean of 25.5 (SD = 8.9).  Ten patients had PNT only and 3 had dual 
pathology. A total of 23.1% (n = 3) of the 13 patients had pulmonary tuberculosis.  
Of the 10 patients with PNT only, 50.0% (n = 5) patients were HIV positive, 
40.0% (n = 4) were HIV negative and 1 patient had an unknown HIV status.  The 
CD4 count of the 5 HIV positive patients with PNT ranged from 140 to 420 
cells/µl with a mean of 240.8 (SD = 113.1) cells/µl.  Lesions were located mainly 
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on the extensors surfaces of extremities, ears, buttocks and healed with 
varioliform scars.  HIV positive patients displayed extensive and atypical follicular 
necrotic skin lesions.  A rare linear subtype was seen in an HIV positive patient 
(fig 6).  Dactylitis of the fingers in association with lesions of PNT was seen in a 
teenager (fig 7). Reaction to PPD was positive in all cases.  
The histology of the biopsy specimens showed epidermal necrosis with 
granulomas in the dermis.  The typical wedge shaped area of necrosis was seen 
in only 38. 5% (n = 5) of patients.  Folliculitis-like histology with necrosis and       
ill- formed granulomas was seen in 23.1% (n = 3), all HIV positive patients.  Acid 
fast bacilli were seen in only one biopsy specimen in a patient with both PNT and 
lupus vulgaris (dual pathology).   
Lichen scrofulosorum occurred in an HIV negative 25 year old patient, initially 
misdiagnosed as lichen nitidus.  Lesions consisted of skin coloured and lichenoid 
asymptomatic papules which were confined to the trunk and upper extremities.  
Histology showed superficial granulomas with multinucleated giant cells but no 
acid fast bacilli were seen.  Her PPD was positive and the lesions responded 
promptly to antituberculous therapy. 
 Four patients had dual pathology.  They were all HIV positive with a mean CD4 
count of 210.5 cells/µl (table 6).  Two cases had erythema induratum, one with 
scrofuloderma and the other with PNT.  The other two patients had PNT with  
lupus vulgaris and scrofuloderma respectively.  PNT was the most common 
overlap skin lesion, seen in 3 of the 4 cases (table 6). 
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Polymerase chain reaction was not done routinely in all the patients.         
Paraffin-embedded tissue specimens from 9/74 patients, 8 with true TB infections  
and 1 with PNT and lupus vulgaris (dual pathology) were subjected to PCR. Four 
tissue specimen (n = 4/9, 44.4% ) had a positive PCR reaction, one with lupus 
vulgaris only, the second with dual pathology (PNT and lupus vulgaris), the third 
with warty TB and the fourth with scrofuloderma.  Cases of orificial and primary 
inoculation TB were found to have a negative PCR but yielded positive growth of 
M. tuberculosis on culture.  The low yield was attributed to poor tissue sampling 
or diminished amplification of mycobacterial DNA.  
Three cases had confirmed multidrug resistance (MDR) to both rifampicin and 
isoniazid.  These included two cases of miliary TB and one with scrofuloderma.  
A total of 6 patients died, four patients with miliary TB died within a month, and 
two patients with scrofuloderma during the 4 month treatment. 
Patients were seen up to 6 months after therapy to assess for relapse. Eight 
patients were lost to follow-up post-treatment.  These 8 patients had received 
anti- TB treatment from their local clinics.  A total of 60 who completed their 
treatment were seen, each patient at least twice in 6 months during the          
post-treatment period.  The lesions had healed well in all patients with no 
evidence of relapse.  Patients with tuberculids responded well to a 6 months 
regimen  therapy and those with true skin infections to a 9 months course.  One 
patient with nodular lupus vulgaris received a 12 months anti-TB treatment after 
failure of resolution of the skin lesions at 9 months.  
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Table 3: Total subtypes of cutaneous (skin) TB lesions and    
               frequency of occurence.  
A total of 74 patients:  70 patients had one skin TB subtype only, 4 had dual  
pathology.  A total of 78 (total skin TB lesions) seen is higher than actual number  
of patients because of the overlap of lesions in 4 patients.  
 
 
Subtypes 
 
One 
subtype 
only 
 
Erythema 
Induratum 
 
Scrofuloderma 
 
PNT 
 
Lupus 
Vulgaris 
 
Total no 
skin TB 
lesions 
Erythema Induratum 25  - 1 1 - 27 
Scrofuloderma 20  1 - 1 - 22 
PNT (Papulonecrotic 
tuberculid)  
10  1 1 - 1 13 
Lupus Vulgaris 5  - - 1 - 6 
Miliary TB 4  - - - - 4 
TB Abscess 2  - - - - 2 
TB Orificialis 1  - - - - 1 
Warty TB 1  - - - - 1 
TB Chancre 1  - - - - 1 
L.Scrofulosorum 1  - - - - 1 
Total 70  2 2 3 1 78 
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Table 4:  True skin TB infections and HIV status 
 
 
Subtypes 
 
Total number 
 of patients 
 N = 74  
 
HIV Negative 
N = 27 
 
HIV Positive 
N = 43 
 
Unknown 
N = 4 
 
P - value 
Scrofuloderma 20 4 15 1 0.005 
Lupus Vulgaris 5 4 1 - 0.028 
Miliary TB 4 - 4 - 0.002 
TB Abscess 2 - 2 - - 
TB Orificialis 1 1 - - - 
Warty TB 1 - 1 - - 
TB Chancre 1 1 - - - 
 
 True Infections 
 
34 
 
10 
 
23 
 
1 
 
P = 0.024 
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Table 5:  Tuberculids and HIV status 
 
 
Subtypes 
 
Patients 
 
HIV Negative 
 
HIV Positive 
 
Unknown 
 
P - Value 
Erythema Induratum 25 12 11 2 P = 0.84 
PNT 10 4 5 1 P = 0.74 
Erthema Induratum + 
PNT  
(Both tuberculids) 
1  
- 1 - - 
L.Scrofulosorum  1 1 -  - 
 
Total 
 
 37 
 
17 
 
17 
 
3 
 
P = 0.71 
 
 
Total number of patients                                                                               74                    
True infections only                                                                                       34                                    
Tuberculids only (including 1 case of 2 overlaping tuberculids)                    37     
Overlap cases : 3 cases (tuberculids + true infections) and 1 case (two tuberculids)     4                                                                                                               
Total number of HIV negative patients:                                                         27   
Total number of HIV positive patients:                                                           43 
Unknown HIV Status                                                                                      4 
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Table 6:  Overlapping skin TB lesions, HIV status and CD4 counts 
 
 
 Overlaps 
 
 Patients 
 
HIV 
Negative 
 
HIV Positive 
 
CD4 counts 
cells/µl 
Scrofuloderma and   
Erythema Induratum 
1 - 1 101 
Scrofuloderma and 
PNT 
1 - 1 170 
Lupus Vulgaris and 
PNT 
1 - 1 301 
Erythema Induratum 
and PNT                 
(both tuberculids) 
1  
Also counted 
under tuberculids 
- 1 
Also counted 
under tuberculids 
270 
Total  4 - 4 Mean CD4          
210.5  
 
 
 
 
 (a) 
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(b) 
(d) 
(a) 
(c) 
Figure 1(a):  Scrofuloderma   Figure 1(b):  Granulomatous infiltrate with 
                     multinucleated giant cells 
Figure 1(c):  Positive acid fast bacilli Figure 1(d):  Resolving lesion after 2nd   
           month of treatment 
(c) (d) 
(a) (b) 
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(a) (a) (a) 
 
(a) 
   
 
  
Figure 2(a):  Nodular lupus vulgaris 
Figure 2(b):  Well formed tuberculoid granulomas 
(a) 
(b) 
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(a) 
(b) 
(a) 
Figure 3(a):  Disseminated cutaneous (miliary) TB 
 Figure 3(b):  Histology of miliary TB showing a neutrophillic infiltrate (pustule) 
       Figure 3(c):  Ziehl Nielsen staining showing abundance of acid fast bacilli 
(a) 
(c) (b) 
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(b) 
(a) 
(b) (a) 
(c) 
       Figure 4(a,c):  TB Orificialis (perianal), before and after treatment 
          Figure 4(b):     Histology showing granulomatous infiltrate with Langhans  
                                         giant cells and caseous necrosis 
(b) (a) 
(c) 
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3.2  Statistical Analysis 
Using the relevant bivariate methods, the spectrum of skin TB was analysed.  
The analysis of the HIV status, CD4 count and their clinical correlation was done 
using the Pearson’s chi-square, Fisher’s exact test and student t - test.  The two 
common subtypes which accounted for more than 60% of all cases, erythema 
induratum and scrofuloderma were analysed in detail.  Seventy five percent 
(15/20) of patients with scrofuloderma compared to 44.0% (11/ 25) of patients 
with erythema induratum were HIV positive.  This translated to a statistically 
significant difference in the HIV positive status between the two subtypes with     
p = 0.039, odds ratio (OR) = 4.1 and 95% confidence interval (CI) = 0.8 - 21.6. 
HIV positive patients with scrofuloderma had a mean CD count of 145.8 cells/µl 
and erythema induratum a mean CD count of 234.5 cells/µl.  The two-sample       
t - test showed a statistically significant CD4 count difference of 88.78 cells/µl            
(95% CI = 29.82 -147.73) with p = 0.041.  
The non-parametric equivalent for the analysis of variance (Anova), namely the 
Kruskal-Wallis equality rank test showed a difference in the mean CD4 counts 
between various skin TB subtypes.  A statistically significant difference was 
found between erythema induratum (CD4 count = 234.5 cells/µl) and PNT               
(CD4 count = 240.5 cells/µl) when plotted against miliary TB (CD4 count = 9.5 
cells/µl) with p value = 0.005 and p = 0.010 respectively.  There were 25.3%       
(n = 18) males and 74.7% (n = 56) females.  Females accounted for 96.0% of all 
cases of erythema induratum and 68.2% of all cases of scrofuloderma.            
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The overall predominance of females resulted in a statistically significant 
difference in gender affected by skin TB with a p = 0.016.  The difference in HIV 
status between true skin infections and tuberculids was recorded.  Sixty seven 
point six percent (67.6%) of patients with true infections were found to be HIV 
positive (n = 23/34) compared to 45.9% of patients with tuberculids (n = 17/37). 
The difference was not statistically significant with p = 0.22, OR = 1.55,              
CI = 0.60 - 406, but showed a trend that patients were more likely to be HIV 
positive if suffering from a true infection rather than from a tuberculid.  Pulmonary 
tuberculosis was found in 39.2% (n = 29) of patients and was significantly higher 
in patients with true skin infections than those with tuberculids.  Analysis of these 
results showed a statistically significant difference with a p = 0.034, OR = 3.38,   
CI = 0.95 -11.16. 
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Chapter 4  
4.1 DISCUSSION 
A total of 74 patients were enrolled for our study over a period of 3 ½ years.  The 
largest study on skin TB in South Africa was done almost 16 years ago at the 
then Ga-Rankuwa hospital, now George Mukhari hospital north west of Pretoria 
in Gauteng over a period of ten years from 1982 -1993. It was a retrospective 
study in which a total of 92 patients were analyzed.  In that study only one patient 
had HIV infection and thus its impact on the clinical presentation of skin TB could 
not be assessed. 
Our study was unique in that it was prospective, multi-centred (three academic 
hospitals) and patients could be followed up regularly to assess their clinical 
response to treatment.  In the present study tuberculids were slightly more 
common than true infections accounting for 50.0% (n = 37) of all cases compared 
to 45.9% (n = 34) of true infections.  The difference was however not statistically 
significant with p = 0.37.  Four patients had dual pathology, i.e both tuberculids 
and true skin infections concurrently, and amongst these patients one had two 
overlapping tuberculids. 
In the largest study in the world on cutaneous TB done in Japan in 2004, 
tuberculids were also reported to be more common than true infections.55 In that 
study a total of 1324 patients seen between the years 1906 - 2002 (almost 100 
years) with cutaneous TB were analyzed.  Tuberculids accounted for 61% of all 
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cases with erythema induratum being seen in 40.5% of all cases.   Similar results 
were reported in the Ga-Rankuwa study in which tuberculids predominated. 
Erythema induratum accounted for 36.5% of all cases in the present study.  
Scrofuloderma was the most common true skin TB infection that we encountered 
whilst lupus vulgaris was the most common true infection seen at Ga-Rankuwa. 
Factors responsible for the resurgence of tuberculosis include the HIV epidemic, 
adverse social conditions, multidrug-resistant tuberculosis and breakdown of 
tuberculosis control programmes.  Some of these were prevalent amongst most 
of our patients, 95% of whom were black.  A closer look at gender revealed that 
females were more commonly affected than males and accounted for 75.6%        
(n = 56) of all cases seen as compared to 24.3% (n = 18) of males.  The 
difference was statistically significant with p = 0.016.  The main reasons were 
unclear but could be partly related to the fact that erythema induratum being the 
most common subtype, affected primarily females.  
The overall prevalence of HIV in the present study was 61.4%.  This is 
comparable to the recorded rates in some of the studies on HIV-TB co-infection 
done in South Africa.  In the study by Naidoo and Douglas from the School of 
Public Health at the University of Witwatersrand, the HIV-TB co-infection rate 
was found to be 46%.56 In the same year in 2007 John et al. from the National 
health laboratory services reported a much higher HIV- TB coinfection rate of 
95%.  The report was based on patients who were admitted in the medical wards 
at the Helen Joseph hospital.57 According to their report the data did not include 
HIV test results of 23.9% (89/373) of their patients. 
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In the HIV positive sub-group of patients with tuberculids, the mean CD4 counts 
were 234.5 cells/µl and 240.5 cells/µl for erythema induratum and PNT 
respectively.  These results highlighted the fact that the majority of patients with 
HIV infection and tuberculids still had a relatively good cell mediated immunity 
with a moderate degree of hypersensitivity to M. tuberculosis.  About 60% of HIV 
positive patients with tuberculids had CD4 count values of above 200 cells/ul. 
This is in contrast to only 30% of HIV positive patients with true skin TB infections 
having CD4 counts of above 200 cells/µl. 
 3.2.1  Clinical features (table 7):  Erythema induratum predominantly affected 
the calves of middle aged women.  There was no significant clinical difference in 
the presentation of these skin lesions in HIV positive and HIV negative patients. 
PNT lesions in HIV positive patients tended to be atypical affecting mainly the ear 
helices, trunk, legs (linear subtype) and buttocks.  Lesions often resembled 
papular follicular eruptions of HIV.  Amongst patients with tuberculids only,     
50.0% (n = 5/10) of patients with PNT were HIV positive compared to 44.0%       
(n = 11/25) of patients with erythema induratum.  The number was less than that 
of scrofuloderma in which 75.0 % (n = 15/20) of patients were HIV positive. Using 
the Fischer exact test, a statistically significant association was found between 
HIV status and scrofuloderma with a p = 0.047.  Of note is that the patients with 
scrofuloderma were predominantly females (n = 15, 68.2%).   
The lesions of scrofuloderma were mainly found on the neck affecting the 
cervical glands in about 80% of cases.  Miliary tuberculosis was seen only in 
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AIDS patients with atypical lesions consisting mainly of erythematous follicular 
and necrotic papules.  The clinical presentation of cases of lupus vulgaris ranged 
from typical plaques to nodular type.  The lesions affected the nose and cheeks 
on the face in 5 patients and the leg in the sixth patient. 
3.2.2  Histopathological features (table 8) of the various subtypes of skin TB 
ranged from granulomatous to non-specific inflammation.  Erythema induratum 
predominantly showed granulomatous inflammation with septolobular 
panniculitis.  A non-granulomatous infiltrate in the HIV positive subgroup with   
CD4 counts of less than 100 cells/µl was seen.  The histology of PNT was less 
striking with the typical wedge shaped area of necrosis demonstrated in 38.4%              
(n = 5/13) of patients.  The histological appearance of scrofuloderma was 
characterized mainly by a granulomatous infiltrate and suppuration.  This was 
less pronounced in the HIV positive group.  M. tuberculosis was cultured in     
45.5% (n = 10/22) of cases.  The histology of lupus vulgaris was mainly 
tuberculoid. Acid fast bacilli were seen in only one biopsy specimen and culture 
was positive in 33. 3% (n= 2) of cases.  The yield of TB culture in lupus vulgaris 
has been reported in previous studies to be around 6%. 
The most striking findings were seen in milliary TB.  All patients had AIDS, with a 
mean CD4 count of 9.5 cells/µl.  The histology showed intradermal pustules with 
a neutrophilic infiltrate, conspicuous absence of a granulomatous reaction and 
abundance of acid fast bacilli on Ziehl Neelsen staining.  A total of 7 patients, 
comprising of 3 with milliary TB, 1 with lupus vulgaris, 2 with scrofuloderma and 
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orificial TB were on anti-TB therapy for one week.  The effect of this short course 
of therapy on the clinical and histological presentation could not be assessed 
objectively.  Tuberculids responded well to a 6 months standard course of      
anti-TB therapy in both non-HIV and HIV infected subgroup of patients.  Patients 
with true infections received a longer course of anti-TB therapy lasting 9 -12 
months.  There was essentially no difference in response to therapy in the two 
subgroups a finding that has previously been reported by Burman in 2005.58 
Three cases had confirmed MDR, which is resistance to both rifampicin and INH.  
These included two cases of miliary TB and one case of scrofuloderma.  All three 
patients were HIV positive and consequently died of AIDS.  No complications e.g 
bony deformities or 20 skin tumours were observed in any of our patients.  
4.2  Limitations  
Patients who were enrolled were seen primarily at the outpatient clinics as well 
as the in medical and general wards.  A number of patients declined to 
participate in the study, consent not could be obtained and were therefore not 
enrolled.  Patients less than 10 years of age were excluded primarily because of 
decreased level of co-operation and the reliability of PPD following BCG 
vaccination.  Some patients with skin TB and organ TB (eg pulmonary or 
meningeal) could well have been treated by clinicians from other disciplines with 
clearance of the skin lesions and no further referral to the dermatology unit 
assessment.  
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Figure 5 (a):  Erythema induratum with ulcerated subcutaneous  
                      nodules affecting the calves 
Figure 5 (b):  Histology showing septo-lobular panniculitis 
(a) 
(a) 
(b) 
(b) 
(a) (b) 
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Figure 5 (c):  Septo-lobular granulomatous panniculitis 
 
Figure 5 (d):  Septo-lobular granulomatous panniculitis with coagulative 
                            necrosis and leukocytoclastic vasculitis 
 
 
 
 
 
 
(b) 
(c) 
(d) 
Figure 5 (d):  Septo-lobular granulomatous panniculitis with coagulative 
                      necrosis and leukocytoclastic vasculitis 
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Figure 6 (a):  Papulonecrotic tuberculid (PNT) affecting the ear helix 
 
 
 
 
 
 
 
 
 
Figure 6 (b):  Linear PNT on the legs of HIV positive patient 
(b) 
(a) 
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Figure 7 (a):  Papulonecrotic tuberculid (PNT) affecting the buttocks 
Figure 7 (b,c):  Dactylitis associated with PNT 
 
(b) 
(c) (a) 
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4.3  CONCLUSIONS 
This was a prospective study which enrolled new patients and may not 
necessarily reflect the true spectrum of cutaneous TB in the general population in 
Johannesburg.  It is evident from this study that the relative frequency of 
cutaneous TB is still low despite the high incidence of organ TB associated with 
HIV/AIDS.  There however appears to be a trend in the pattern with a relative 
increase in true cutaneous TB infections particularly scrofuloderma.  Tuberculids 
were marginally more common than true infections but the difference was not 
statistically significant with a p = 0.37.  Erythema induratum was still the most 
common form of cutaneous TB seen, accounting for 36.5% of all the study 
patients, followed by scrofuloderma which accounted for 29.7% of all cases. 
Cutaneous disseminated (miliary) TB continues to be rare and carries a high 
mortality.  There was a significant statistical association between HIV infection 
and true cutaneous TB infections (p = 0.024) and not with tuberculids (p = 0.71).  
The difference between the clinical and histopathological patterns of the 
cutaneous TB lesions between the HIV positive and HIV negative patients 
depended largely on the subtype and immunological status.  Further studies are 
necessary to look into the cytokine profile, cell adhesion molecules and               
T-lymphocytes sub-populations in lesional skin to elucidate the immunological 
mechanisms responsible for the paucity of cutaneous TB lesions despite the high 
prevalence of pulmonary and extrapulmonary TB especially in the setting of    
HIV/AIDS. 
(b) (c) 
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Table 7:  True skin TB infections – Clinical and Pathological Features  
 
Subtypes of 
skin TB 
Patients Clinical 
features 
PPD   Culture 
  
Histopathology 
 
Scrofuloderma 22 Nodules, 
sinuses, ulcers,  
neck (80%), 
submandibular 
+  
45.5% +ve 
(10/22 pts) 
Granulomas and mixed  
infilrate with necrosis &  
abscesses, AFB +ve in  
7/22 pts (31.8%) 
Lupus Vulgaris 6 Nodules, 
plaques - face 
(85%)  
+  33,3% 
+ve 
(2/6 pts) 
Tuberculoid granulomas.  
 Mild caseation necrosis  
 AFB +ve in 1 pt (16.5%) 
Miliary TB 4 Erythematous,  
follicular and 
necrotic 
papules 
-  
100% +ve 
  (4/4 pts) 
Inflammatory infiltrate, 
microabscesses,   
 AFB +ve in 4 pts (100%) 
TB Abscess 2 Ulcers, 
abscesses on 
the legs 
+  50% +ve 
 1 pt 
Necrosis, abscesses,   
 AFB +ve 2 pts 
Orificial TB  1 Shallow ulcers 
perianally 
+ + ve Granulomatous infiltrate,  
AFB +ve 
Warty TB  1 Warty plaque 
on the hand 
+ + ve Pseudo-epitheliomatous 
hyperplasia with  
granulomas, AFB +ve 
TB Chancre 1 Indurated 
papulonodule 
on the finger 
+ Not done Mixed infiltrate with  
Granulomas, AFB +ve 
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Table 8:  The Tuberculids – Clinical and Pathological features 
 
Subtypes of 
skin TB 
Patients Clinical features PPD AFB Histopathology 
Erythema 
Induratum 
27 Indurated ±  
ulcerated tender  
nodules – calves 
+ - Septolobular panniculitis.  
granulomas   ± vasculitis 
PNT 13 Dusky red  
necrotic  papules  
legs, extensors,  
buttocks, ears 
+ -   
           
1 +ve 
Granulomas. Wedge  
shaped areas of necrosis & 
folliculitis-like histology 
Lichen 
scrofulosorum 
1 Grouped  
perifollicular  
papules, trunk 
+ - Epitheloid granulomas with 
Langhans giant cells in the  
upper dermis 
Nodular 
tuberculid 
Not seen    - - - - 
Nodular 
granulomatous 
phlebitis 
Not seen     - - - - 
+  indicates positive 
 -  indicates negative 
AFB = Acid fast bacilli 
PPD = Purified protein  derivative (Mantoux) 
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Diagram 1:  Pie chart.  Male : Female Ratio = 1:3 
 
 
   
 Males  n = 18 
(24.3% )
F emales  n = 56 
(75.7% )
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Diagram 2:  Overall skin TB subtypes plotted against HIV status 
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Diagram 3: CD4 counts in the HIV positive patients (Overlaps excluded) 
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Table 9: CD4 counts in the HIV positive patients (Overlaps excluded) 
Subtypes of skin TB No. of HIV+ve patients  Mean CD4 count cells/µl 
Scrofuloderma             15           145.8 
L. Vulgaris              1            95 
Miliary TB              4            9.5 
TB Abscess              2           148.5 
Warty TB              1           280 
E. Induratum             11           234.5 
PNT              5           240.8 
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Diagram 4:  Skin TB subtypes plotted against gender 
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LEGENDS TO FIGURES 
1.  Figure 1 (a).  Scrofuloderma presenting as an ulcer on the neck. 
                   (b).  Histology showing granulomatous infiltrate with giant cells. 
                   (c).  Positive acid fast bacilli on the tissue specimen. 
                   (d).  Resolving lesions after 2 months of therapy. 
 
2.  Figure 2 (a).  Nodular lupus vulgaris. 
                   (b).  Well formed tuberculoid granulomas. 
 
3.  Figure 3 (a).  Miliary TB presenting with erythematous follicular papules. 
                   (b).  Histology showing an intradermal pustule. 
                   (c).  Abundance of acid fast bacilli on Ziehl Neelsen staining. 
 
4.  Figure 4.  TB orificialis perianally (a) before and (b) after treatment. 
 
5.  Figure 5 (a).  Subcutaneous lesions of erythema induratum on the calves.  
                    (b).  Histology of erythema induratum showing panniculitis. 
                    (c).  Histology showing septo-lobular granulomatous panniculitis 
                    (d).  Close-up showing coagulative necrosis with leukocytoclastic       
                            vasculitis.  
 
6.  Figure 6 (a).  Papules on the ear in a patient with papulonecrotic tuberculid. 
                    (b).  Linear papulonecrotic tuberculid affecting the both legs. 
 
7.  Figure7 (a).  Lesions of papulonecrotic tuberculid affecting the buttocks. 
                (b,c).  Dactylitis associated with papulonecrotic tuberculid. 
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